129 related articles for article (PubMed ID: 15760645)
1. Cholesterol homeostasis failure as a unifying cause of synaptic degeneration.
Koudinov AR; Koudinova NV
J Neurol Sci; 2005 Mar; 229-230():233-40. PubMed ID: 15760645
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol, synaptic function and Alzheimer's disease.
Koudinov AR; Koudinova NV
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S107-12. PubMed ID: 14574623
[TBL] [Abstract][Full Text] [Related]
3. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-beta, tau protein, and oxidative changes as a physiological compensatory mechanism to maintain CNS plasticity under Alzheimer's disease and other neurodegenerative conditions.
Koudinov A; Kezlya E; Koudinova N; Berezov T
J Alzheimers Dis; 2009; 18(2):381-400. PubMed ID: 19749430
[TBL] [Abstract][Full Text] [Related]
5. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
Rowan MJ; Klyubin I; Wang Q; Anwyl R
Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol modulates amyloid beta-peptide's membrane interactions.
Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
[TBL] [Abstract][Full Text] [Related]
7. Synaptic plasticity in animal models of early Alzheimer's disease.
Rowan MJ; Klyubin I; Cullen WK; Anwyl R
Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):821-8. PubMed ID: 12740129
[TBL] [Abstract][Full Text] [Related]
8. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A
Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and Abeta toxicity: from top to bottom.
Small DH; Mok SS; Bornstein JC
Nat Rev Neurosci; 2001 Aug; 2(8):595-8. PubMed ID: 11484003
[No Abstract] [Full Text] [Related]
10. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol trafficking and amyloid beta peptides.
Wood WG; Igbavboa U
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S144-8. PubMed ID: 14574629
[TBL] [Abstract][Full Text] [Related]
12. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.
Zetterberg H
Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126
[TBL] [Abstract][Full Text] [Related]
13. [Cholesterol is an important molecule in the processes of the synaptic plasticity and degeneration of neurons].
Kudinov AR; Kudinova NV; Berezov TT
Vestn Ross Akad Med Nauk; 2006; (9-10):61-6. PubMed ID: 17111927
[TBL] [Abstract][Full Text] [Related]
14. [Studying pathogenesis of Alzheimer's disease in a Drosophila melanogaster model: human APP overexpression in the brain of transgenic flies leads to deficit of the synaptic protein synaptotagmin].
Sarantseva SV; Bol'shakova OI; Timoshenko SI; Rodin DI; Vitek MP; Shvartsman AL
Genetika; 2009 Jan; 45(1):119-26. PubMed ID: 19239106
[TBL] [Abstract][Full Text] [Related]
15. Synaptic degeneration in Alzheimer's disease.
Arendt T
Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
[TBL] [Abstract][Full Text] [Related]
17. FAD-mutation of APP is associated with a loss of its synaptotrophic activity.
Seeger G; Gärtner U; Ueberham U; Rohn S; Arendt T
Neurobiol Dis; 2009 Aug; 35(2):258-63. PubMed ID: 19450683
[TBL] [Abstract][Full Text] [Related]
18. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
Sorrentino G; Bonavita V
Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
[TBL] [Abstract][Full Text] [Related]
19. Calcium dysregulation in Alzheimer's disease.
Bojarski L; Herms J; Kuznicki J
Neurochem Int; 2008; 52(4-5):621-33. PubMed ID: 18035450
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease sends the wrong signals--a perspective.
Neve RL
Amyloid; 2008 Mar; 15(1):1-4. PubMed ID: 18266116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
